Cirtuvivint

A Phase I Study Evaluating the Safety of Cirtuvivint as Monotherapy and in Combination With ASTX727 and ASTX727 + Venetoclax in Patients With Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)

Near Add Your Location

Sorting 16 by

MDS Center of Excellence

  • Accepting patients
  • Show Principal Investigator
  • Accepting patients
  • Show Principal Investigator
  • Accepting patients
  • Show Principal Investigator

MDS Center of Excellence

Rutgers Cancer Institute of New Jersey
Rutgers, The State University of New Jersey
New Brunswick, NJ
  • Accepting patients
  • Accepting patients
  • Show Principal Investigator

MDS Center of Excellence

  • Accepting patients

MDS Center of Excellence

  • Accepting patients
  • Accepting patients
  • Show Principal Investigator

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print this trial to share with your doctor.

We can help answer any questions and connect you (or your patient) with the study team.

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.